Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-17T04:46:47.917004+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/companies/pelthos-therapeutics-inc.md
Open Markdown

Pelthos Therapeutics Inc.

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-1
Canonical entityalpha:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716
Entity typeCompany
Canonical URLhttps://registry.alpha.ac/companies/pelthos-therapeutics-inc
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims14
Claims under review1
Evidence records4
Conflicts0
Conflicts in internal review0
Observed2026-09-17T04:46:47.917004+00:00
Last reviewed2026-09-17T04:46:47.917004+00:00

Identity

  • Legal name: Pelthos Therapeutics Inc.
  • Display name: Pelthos Therapeutics Inc.

Leadership

  • Peter Greenleaf: Chairman of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:2.
  • Andrew Einhorn: Director. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:3.
  • Ezra Friedberg: Director. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:3.
  • Matthew Pauls: Director. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:3.
  • Richard Baxter: Director. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:3.
  • Scott Plesha: Director, Chief Executive Officer and President. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:2.
  • Todd Davis: Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:3.
  • Francis Knuettel II: Chief Financial Officer, Treasurer and Secretary. Valid from: 2026-03-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:4.
  • John M. Gay: Chief Financial Officer, Secretary and Treasurer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:2.
  • Sai Rangarao: Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:2.
  • Scott Plesha: Chief Executive Officer and President. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:2.

Roles

  • PUBLISHED

Governance

  • NOT_ASSERTED

Board committees

  • PUBLISHED

Financials

  • NOT_ASSERTED

Workforce

  • NOT_ASSERTED

Market and index context

  • PUBLISHED

Legal Name

  • Pelthos Therapeutics Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:1.

Headquarters

  • US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

  • Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:1.

Published Fact

  • US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716:1.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessPUBLISHED
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernanceNOT_ASSERTED
FinancialsNOT_ASSERTED
WorkforceNOT_ASSERTED
OwnershipNOT_ASSERTED
RatingsNOT_PUBLISHED
Market and index contextPUBLISHED

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations